Enzo Biochem Gestion
Gestion contrôle des critères 0/4
Enzo Biochem's CEO is Kara Cannon, appointed in Sep 2023, has a tenure of 1.17 years. total yearly compensation is $1.22M, comprised of 24.4% salary and 75.6% bonuses, including company stock and options. directly owns 0.53% of the company’s shares, worth $311.29K. The average tenure of the management team and the board of directors is 1.2 years and 1.1 years respectively.
Informations clés
Kara Cannon
Directeur général
US$1.2m
Rémunération totale
Pourcentage du salaire du PDG | 24.4% |
Durée du mandat du directeur général | 1.2yrs |
Propriété du PDG | 0.5% |
Durée moyenne d'occupation des postes de direction | 1.2yrs |
Durée moyenne du mandat des membres du conseil d'administration | 1.1yrs |
Mises à jour récentes de la gestion
Recent updates
Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jul 31 2024 | n/a | n/a | -US$10m |
Apr 30 2024 | n/a | n/a | -US$18m |
Jan 31 2024 | n/a | n/a | -US$23m |
Oct 31 2023 | n/a | n/a | -US$25m |
Jul 31 2023 | US$1m | US$299k | -US$25m |
Apr 30 2023 | n/a | n/a | -US$27m |
Jan 31 2023 | n/a | n/a | -US$24m |
Oct 31 2022 | n/a | n/a | -US$23m |
Jul 31 2022 | US$769k | US$270k | -US$20m |
Apr 30 2022 | n/a | n/a | -US$7m |
Jan 31 2022 | n/a | n/a | US$300k |
Oct 31 2021 | n/a | n/a | US$5m |
Jul 31 2021 | US$426k | US$265k | US$8m |
Apr 30 2021 | n/a | n/a | US$1m |
Jan 31 2021 | n/a | n/a | -US$11m |
Oct 31 2020 | n/a | n/a | -US$21m |
Jul 31 2020 | US$371k | US$220k | -US$29m |
Apr 30 2020 | n/a | n/a | -US$31m |
Jan 31 2020 | n/a | n/a | US$2m |
Oct 31 2019 | n/a | n/a | US$822k |
Jul 31 2019 | US$379k | US$220k | US$2m |
Apr 30 2019 | n/a | n/a | US$2m |
Jan 31 2019 | n/a | n/a | -US$23m |
Oct 31 2018 | n/a | n/a | -US$16m |
Jul 31 2018 | US$342k | US$198k | -US$10m |
Rémunération vs marché: Kara's total compensation ($USD1.22M) is above average for companies of similar size in the UK market ($USD369.71K).
Rémunération et revenus: Kara's compensation has increased whilst the company is unprofitable.
PDG
Kara Cannon (55 yo)
1.2yrs
Titularisation
US$1,221,793
Compensation
Ms. Kara Cannon serves as Chief Executive Officer at Enzo Biochem, Inc. from January 31, 2024 and serves as its Director from 2024 and served as its Interim CEO since September 5, 2023 until January 31, 20...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO & Director | 1.2yrs | US$1.22m | 0.53% $ 311.3k | |
Chief Financial Officer | 2yrs | US$453.56k | 0.037% $ 21.9k | |
General Counsel | less than a year | pas de données | pas de données |
1.2yrs
Durée moyenne de l'emploi
53yo
Âge moyen
Gestion expérimentée: 0IHV's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
CEO & Director | less than a year | US$1.22m | 0.53% $ 311.3k | |
Independent Chairperson of the Board | 1.1yrs | pas de données | 0.034% $ 20.0k | |
Independent Director | 2.8yrs | US$195.00k | 8.07% $ 4.8m |
1.1yrs
Durée moyenne de l'emploi
55yo
Âge moyen
Conseil d'administration expérimenté: 0IHV's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.